Australia develops intelligent hi-res retinal camera

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

Singapore: The Australian Government's Cooperative Research Center (CRC) Program is providing susbtantial amounts of funds to researchers in order to develop the Intelligent Retinal Camera ...Read more

IDT appoints Paul MacLeman as CEO

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

Singapore: IDT Australia appointed Dr Paul MacLeman as CEO, effective April 15, 2013. Dr MacLeman was recently the CEO of Melbourne-based biotechnology company Genetic Technologies, where h...Read more

Obese children more prone to Asthma: Study

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Researchers from the UK and Australia proved in a study that excess weight and obesity among children was a major reason contributing to Australia's high rates of asthma. The st...Read more

Dr Brian McNamee to step down from CSL

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

Singapore: After 23 years of being at the helm of CSL, Dr Brian McNamee will leave the firm in July 2013 and will be succeeded by Mr Paul Perreault, who is currently the president of CSL Be...Read more

Canada's investment giant enters Aus life science

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

On October 25, 2012, Canada-based international investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a high profile life sciences team. Canaccord Genu...Read more

Celgene's anti-cancer drug reactivates dormant HIV: Study

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: A study presented by Danish scientists at the AIDS 2014 conference, indicated that an anti-cancer drug made by US biotech firm Celgene could reactivate dormant HIV in patients, f...Read more

BioDiem expands antimicrobial profile

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agreement with Griffith University to expand the range of formulations of...Read more

Pharma companies set eyes on China

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

Alchemia cancer trial gets nod from drug safety board

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's phase III, double blind, randomized, pivotal ...Read more

Alchemia gets new CEO

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more

Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

What the future holds for the APAC CRO market?

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Indo-Aussie research to find ovarian cancer cure

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

Changes in PBS to help Aussies save $20 mn

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

Singapore: The listings and price changes that came into effect in Australia this August through the Pharmaceutical Benefits Scheme (PBS) is said to see saving of $20 million a year. Furth...Read more

Intl anesthesia society appoints board members

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

Singapore: SmartTots, a research initiative sponsored by International Anesthesia Research Society, a non-political medical society that supports anesthesia research and education, has appo...Read more

Australian firm registers 25 disease specific stem cell lines at NIH

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been successful in registering 25 of its disease specific embryonic pluripotent s...Read more

Trial begins for vaccine that builds gluten tolerance

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

Adhesive patch to deliver drugs

Australia |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

One of the promising alternative drug delivery technologies is a transdermal delivery platform called targeted pentration matrix (TPM). Australia-based Phosphagenics has been working to dev...Read more